Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes*

Elanco (NYSE: ELAN) launched the Advantage™ Collar for Dogs on April 9, 2026, offering four months of continuous protection against fleas, ticks and repelling mosquitoes* for dogs and puppies 12 weeks and older.

Rhea-AI Summary

Elanco (NYSE: ELAN) launched the Advantage™ Collar for Dogs on April 9, 2026, offering four months of continuous protection against fleas, ticks and repelling mosquitoes* for dogs and puppies 12 weeks and older.

The adjustable, time-release collar strengthens Elanco's 25-year Advantage brand, will be sold at pet specialty, dollar, grocery and mass retailers, and has a suggested retail price below $25**. Excludes California for the mosquito claim.

Positive

• 4 months continuous parasite protection per application
• Suggested retail price below $25 for broad consumer appeal
• Distribution across pet specialty, dollar, grocery and mass retailers
• Builds on 25-year Advantage brand heritage

Negative

• Mosquito claim excludes California, limiting nationwide claim applicability

Argus Apr 9 session

-0.59% close to close Open Argus

Details

News Market Reaction – ELAN

On Apr 9, the day this news came out, ELAN closed 0.59% below the previous close.

Data tracked by StockTitan Argus for the Apr 9 session.

Market Context

This announcement adds a new OTC option to Elanco’s pet health lineup, offering four months of conti...

Analysis

This announcement adds a new OTC option to Elanco’s pet health lineup, offering four months of continuous flea, tick and mosquito* protection and an advertised price below $25. It builds on the 25-year Advantage brand and targets broad retail channels, from pet specialty to mass merchants. In context of recent revenue growth and innovation targets, investors may watch for adoption trends of this collar, contribution to pet segment sales, and execution versus previously communicated 2026 guidance.

Key Figures

Protection duration: 4 months Minimum dog age: 12 weeks Application frequency: 3 times per year +2 more

Protection duration

4 months

Continuous flea, tick and mosquito* protection per collar

Minimum dog age

12 weeks

Eligible age for dogs and puppies using the collar

Application frequency

3 times per year

Collar changes needed for year-round coverage

Suggested retail price

Below $25

Indicative OTC pricing at retail channels

Advantage brand history

25 years

Age of Elanco’s Advantage brand family

Historical Context

5 past events · Latest: Feb 24

5 events

1. Feb 24

   Q4/FY25 earnings

   24h Move

   +6.6%

   Reported FY25 revenue $4,715M and raised 2026 innovation targets.

2. Feb 19

   Investor conferences

   24h Move

   +1.7%

   Announced management participation in multiple upcoming investor conferences.

3. Feb 13

   Board changes

   24h Move

   +1.4%

   Two directors not standing for re-election; board to consist of nine members.

4. Jan 22

   Earnings call date

   24h Move

   +2.5%

   Confirmed date and call details for Q4 and FY25 results announcement.

5. Jan 06

   JPM conference

   24h Move

   +3.3%

   Planned participation in 44th J.P. Morgan Healthcare Conference with leadership.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

insect growth regulator, lyme disease, anaplasmosis, rocky mountain spotted fever, +1 more

5 terms

insect growth regulator medical

"Breaks the flea lifecycle* with Pyriproxyfen, an insect growth regulator, preventing..."

An insect growth regulator is a type of pesticide that prevents insects from maturing, reproducing or shedding their outer shell, often by disrupting normal development rather than killing on contact; think of it as a growth blocker that stops larvae from becoming adults. Investors care because these products can offer longer-term pest control, different regulatory and safety profiles, and steady demand in agriculture, public health and consumer markets, which affects sales, margins and regulatory risk.

lyme disease medical

"kills ticks that may transmit diseases such as Lyme disease, anaplasmosis..."

An infection spread by tick bites caused by bacteria that can lead to fever, fatigue, joint pain, and neurological or heart problems if untreated. Investors track it because diagnosis, treatment, prevention tools, and long-term care drive demand for diagnostics, drugs, and medical services, and changes in case numbers, regulatory approvals, or reimbursement can affect companies in those markets. Think of it as a seasonal public-health risk that influences related health-care businesses.

anaplasmosis medical

"kills ticks that may transmit diseases such as Lyme disease, anaplasmosis, and Rocky..."

Anaplasmosis is a bacterial infection spread mainly by ticks that can make humans and animals sick with fever, fatigue, and flu‑like symptoms; in livestock it can cause weakness and reduced productivity. Investors track it because outbreaks drive demand for diagnostics, treatments, vaccines, and can disrupt agricultural output or raise healthcare and insurance costs—think of it as a hidden pest that can dent earnings and create market opportunities for companies offering solutions.

rocky mountain spotted fever medical

"diseases such as Lyme disease, anaplasmosis, and Rocky Mountain spotted fever..."

A serious infectious illness spread by tick bites, caused by a bacteria that can damage blood vessels and organs if not treated promptly. It matters to investors because outbreaks, diagnostic gaps, or new treatments can affect healthcare demand, regulatory reviews, insurance costs, workplace absenteeism and the financial outlook for drug makers, diagnostic companies, and public health services—similar to how a sudden software bug can reveal the need for fixes and drive spending on solutions.

tapeworms medical

"and kills fleas that may carry tapeworms."

Tapeworms are long, flat parasitic worms that live inside the intestines of humans and animals, absorbing nutrients from their hosts much like a thief living off someone else’s grocery supply. For investors, they matter because infections influence demand for pharmaceuticals, diagnostics and animal‑health products, can affect public‑health spending or livestock productivity, and may change regulatory and market dynamics for companies addressing parasitic disease.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

• Breaks the flea lifecycle* with Pyriproxyfen, an insect growth regulator, preventing fleas from reinfesting the dog
• Adjustable collar fits comfortably and securely on a dog of any size
• Strengthens Elanco's 25-year Advantage brand family
• Available at pet specialty, dollar, grocery and mass retailers, with a suggested retail price below $25**

INDIANAPOLIS, April 9, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the launch of its Advantage™ Collar for Dogs, a new product providing long-lasting protection against two parasites that don't take a season off – fleas and ticks. Designed for dogs and puppies 12 weeks of age and older, this dog collar kills and repels fleas and ticks and repels mosquitoes* for a full four months.

"The Advantage Collar for Dogs is a fantastic addition to our over-the-counter pet portfolio, building on the 25-year Advantage brand family and Elanco's leadership in the retail space," said Bobby Modi, Executive Vice President, U.S. Pet Health and Global Digital Transformation at Elanco. "Elanco is proud to offer a variety of products at multiple price points, meeting the consumer where they want to shop whether it be at retail or through the veterinarian."

Fleas and ticks are active year-round, even in the cold winter months, meaning it is important for dogs to be on year-round flea and tick control. The Advantage Collar for Dogs provides four months of continuous flea, tick and mosquito* protection by using the collar's time-release formula for four months of coverage, allowing dog owners to apply the collar only three times per year for round-the-clock protection.

The collar also kills ticks that may transmit diseases such as Lyme disease, anaplasmosis, and Rocky Mountain spotted fever and kills fleas that may carry tapeworms.

"As we head into peak parasite season, I encourage pet owners to find the right flea and tick protection for their dogs," said Dr. Casey Locklear, parasiticide lead at Elanco. "The Advantage Collar for Dogs offers a new option for dog parents looking for an affordable, over-the-counter treatment option. Whether your dog enjoys long hikes or playing in the yard, year-round flea and tick control is crucial."

The Advantage Collar for Dogs is available at pet specialty, dollar, grocery and mass retailers. Learn more here: https://yourpetandyou.elanco.com/us/our-products/advantage-collar-dog

For more information on Elanco's vast portfolio of parasite control products visit https://yourpetandyou.elanco.com/us/our-products.

*Excluding California

** Retailers may sell at a different price

ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With 70 years of animal health heritage, we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our purpose – all to Go Beyond for Animals, Customers, Society and Our People. Learn more at www.elanco.com.

Investor Contact: Tiffany Kanaga (765) 740-0314 tiffany.kanaga@elancoah.com
Media Contact: Season Solorio (765) 316-0233 season.solorio@elancoah.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/elanco-launches-advantage-collar-for-dogs-with-four-months-of-continuous-protection-from-fleas-ticks-and-mosquitoes-302737537.html

SOURCE Elanco Animal Health

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What protection period does Elanco's Advantage Collar (ELAN) provide for dogs announced April 9, 2026?

It provides a direct four months of continuous protection against fleas and ticks and repels mosquitoes for four months. According to Elanco, the collar uses a time-release formula so owners need three applications per year for year-round protection.

How does the Advantage Collar for Dogs (ELAN) work to prevent flea reinfestation?

The collar uses pyriproxyfen to interrupt the flea lifecycle and prevent reinfestation. According to Elanco, pyriproxyfen is an insect growth regulator that helps stop immature flea stages from developing into biting adults.

Where will Elanco's Advantage Collar for Dogs (ELAN) be sold and what is the price range?

The collar will be sold at pet specialty, dollar, grocery and mass retailers with a suggested retail price below $25. According to Elanco, retailers may set different prices, so local shelf price can vary.

Is the Advantage Collar for Dogs (ELAN) suitable for puppies and small dogs?

Yes, it is suitable for dogs and puppies aged 12 weeks and older and is adjustable to fit any size. According to Elanco, the adjustable collar is designed to fit comfortably and securely across dog sizes.

Does Elanco's Advantage Collar (ELAN) protect against disease‑carrying ticks?

The collar kills ticks that may transmit Lyme disease, anaplasmosis, and Rocky Mountain spotted fever. According to Elanco, that tick-killing activity helps reduce the risk of those tick-borne pathogens on treated dogs.

Are there any geographic limitations to the Advantage Collar's mosquito claim for ELAN announced April 9, 2026?

Yes, the mosquito repellent claim explicitly excludes California. According to Elanco, the exclusion means the mosquito repellent benefit does not apply in California despite the collar's nationwide retail availability.